<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04465448</url>
  </required_header>
  <id_info>
    <org_study_id>JSY_2020_25</org_study_id>
    <nct_id>NCT04465448</nct_id>
  </id_info>
  <brief_title>Evaluation of the Reproducibility of the Measurement of the QSM Signal (Quantitative Susceptibility Mapping)</brief_title>
  <acronym>ERESI</acronym>
  <official_title>Evaluation of the Reproducibility of the Measurement of the QSM Signal (Quantitative Susceptibility Mapping)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Those included will perform an MRI without injection to obtain the QSM then they will exit
      the machine and reinstall themselves there to perform the second measurement. They will then
      change the MRI machine to perform a third measurement
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2020</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>QSM signal difference at two acquisition times in white matter, on an individual scale</measure>
    <time_frame>baseline</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">58</enrollment>
  <condition>Evaluate the Intra-individual Reproducibility of the QSM Signal Measurement in White Matter</condition>
  <arm_group>
    <arm_group_label>healthy volunteers</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>group case</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>Those included will perform an MRI without injection to obtain the QSM then they will exit the machine and reinstall themselves there to perform the second measurement. They will then change the MRI machine to perform a third measurement</description>
    <arm_group_label>group case</arm_group_label>
    <arm_group_label>healthy volunteers</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participation in the study will be offered to patients with MS (the primary indication for
        which QSM is studied) as well as to healthy volunteers among staff.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Subject over 18 years old Consent to participate in the study Beneficiary of a social
        protection scheme For healthy volunteers: Consent to be informed if an unexpected anomaly
        is revealed by the imagery.

        For patients: With MS defined according to McDonald's revised criteria for spatial
        dissemination and temporal or clinical or radiological temporal dissemination and who
        should benefit from MRI in the imaging department

        Exclusion Criteria:

        Absolute contraindication to 3T MRI Realization of an injected MRI (gadolinium) in the
        previous year Patient benefiting from a legal protection measure Pregnant or breastfeeding
        womanFor healthy volunteers: History of neurological pathology or neurological pathology in
        progress
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Amelie YAVCHITZ</last_name>
    <phone>0148036454</phone>
    <email>ayavchitz@for.paris</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>julien savatovsky</last_name>
    <phone>0148036401</phone>
    <email>jsavatovsky@for.paris</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hhopital fondation adolphe de rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Amelie ya</last_name>
      <phone>0148036454</phone>
      <email>ayavchitz@for.paris</email>
    </contact>
    <investigator>
      <last_name>julien savatovsky</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 7, 2020</study_first_submitted>
  <study_first_submitted_qc>July 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 10, 2020</study_first_posted>
  <last_update_submitted>July 7, 2020</last_update_submitted>
  <last_update_submitted_qc>July 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease Susceptibility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

